Search
Inventiva SA
IVAAdd to Watchlist
3.910USD
+0.220+5.96%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
884.47MMarket Cap
--P/E TTM
More Details of Inventiva SA Company
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Inventiva SA Info
Ticker SymbolIVA
Company nameInventiva SA
IPO dateFeb 15, 2017
CEOObenshain (Andrew)
Number of employees- -
Security typeDepository Receipt
Fiscal year-end- -
Address50 rue de Dijon
CityDAIX
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryFrance
Postal code21121
Phone33380447500
Websitehttps://inventivapharma.com/
Ticker SymbolIVA
IPO dateFeb 15, 2017
CEOObenshain (Andrew)
Company Executives of Inventiva SA
Name
Name/Position
Position
Shareholding
Change
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Ms. Alice Roudot-Ketelers
Ms. Alice Roudot-Ketelers
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Eric Duranson
Mr. Eric Duranson
General Counsel
General Counsel
--
--
Ms. Pascaline Clerc
Ms. Pascaline Clerc
Executive Vice President - Strategy and Corporate Affairs
Executive Vice President - Strategy and Corporate Affairs
--
--
Dr. Mark Pruzanski, M.D.
Dr. Mark Pruzanski, M.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Srinivas (Srini) Akkaraju, M.D., Ph.D.
Dr. Srinivas (Srini) Akkaraju, M.D., Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Ms. Alice Roudot-Ketelers
Ms. Alice Roudot-Ketelers
Chief Operating Officer
Chief Operating Officer
--
--
FAQs
Who are the top five shareholders of Inventiva SA?
The top five shareholders of Inventiva SA are: Mr. Jean Volatier
How many institutions hold shares of Inventiva SA (IVA)?
As of 2026Q1, 63 institutions hold shares of Inventiva SA, with a combined market value of approximately 49.29M, accounting for 25.51% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 35581870.00.